 In this episode of The Heartbeat, we continue our discussion with Dr. Black and Dr. Jaworski of XN Health to better understand the pathway to improve innovative devices. There's a lot of testing that goes into medical device development. We want to make sure that a device is very safe before we put it into humans. So we do a lot of bench-top testing, making sure that when we develop this device that there's no alter indications or nothing else happening to our patients. We're hoping to start a clinical trial within the next three or four years and that'll give us time to ensure that the device is up to standards. And so there is a process of going and communicating with the FDA to make sure that we've hit all these milestones of safety and efficacy and we get a lot of feedback from clinicians to make sure that we're considering all these important factors. And so Ballpark, how much does something like this cost to launch? Yeah, so from zero, the idea all the way to being treated in the first patient, we're talking probably around 50 to 75 million, maybe even a little bit more depending on how those studies actually transpire. When we start doing our human trials, those are very costly for managing patients at that time and following them. Wow, that's a lot of funding. More than I thought. But I mean, considering the benefits that it poses to patients, it is a priceless technology and innovation. Yeah, it requires a certain type of a special investor who has the patience to invest into a very long pathway of research and development before there's actually any revenue. So unlike other businesses where you can prove out your case within a couple of years, it doesn't require sometimes five, seven, even more years just to research and develop the technology. What we applied to a couple of accelerators and one that really stuck out to me was the HAX Accelerator sponsored by SOSD. And so this is an accelerator that focuses a lot on hard tech and engineering and the product development. And that was something that we really needed to work a lot on. We had spent the last year validating the need a lot, speaking to a bunch of clinicians within this medical center and validating that the concept had merit. And so now we just really needed to bring that product to the next stage. And so that's what the HAX Accelerator is going to do for us. It comes with a little bit of investment and a huge engineering team to support us in this next endeavor. We're going to continue building with the Texas Heart Institute. They have supported us through the Roderick McDonald's fund. There's a research grant that Baylor St. Luke's Texas Heart Institute supports. We will always keep our roots here in Houston. You know, this is the largest medical center in the country and so there's huge value here. We have, you know, incredible teams of clinicians here that we hope to continue to leverage on. Dr. Meteorzavi is here in his team and so we're always excited to come back. For the heartbeat, I'm Maya Pomroy.